Welcome to our dedicated page for Sotera Health news (Ticker: SHC), a resource for investors and traders seeking the latest updates and insights on Sotera Health stock.
Sotera Health Company provides sterilization solutions, lab testing and advisory services for the healthcare industry through Sterigenics, Nordion and Nelson Labs. News about SHC commonly covers quarterly and annual operating results, constant-currency revenue trends, Adjusted EBITDA commentary and outlook updates across those businesses.
Recurring company developments also include segment performance in outsourced terminal sterilization, irradiation services and laboratory testing, as well as governance changes, board committee assignments and capital-structure activity involving its Nasdaq-listed common stock. Sterigenics uses gamma irradiation, EO processing and E-beam irradiation for medical device, pharmaceutical, food safety and other application markets.
Sotera Health Company (Nasdaq: SHC) will be represented by Chairman and CEO Michael B. Petras, Jr. at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021, at 7:30 am ET. This leading global provider focuses on end-to-end sterilization solutions and lab testing services for healthcare. Interested investors can access the live and archived webcast via Sotera Health's Investor Relations page.
Sotera Health operates through three divisions: Sterigenics®, Nordion®, and Nelson Labs®, with a commitment to Safeguarding Global Health®.
Sotera Health Company (Nasdaq: SHC) has successfully closed its initial public offering (IPO) of 53,590,000 shares at $23.00 each, generating approximately $1.2 billion in gross proceeds. The offering involved prominent financial institutions: J.P. Morgan, Credit Suisse, Goldman Sachs & Co. LLC, and Jefferies, among others. The registration statement was declared effective on November 19, 2020, by the SEC. Sotera Health focuses on end-to-end sterilization solutions and lab testing services for healthcare, committed to its mission of Safeguarding Global Health®.
Sotera Health Company has priced its initial public offering (IPO) of 46,600,000 shares at $23.00 each, aiming for gross proceeds of approximately $1.1 billion. The shares will begin trading on the Nasdaq under the symbol 'SHC' on November 20, 2020, and the offering is expected to close on November 24, 2020. Underwriters include J.P. Morgan, Credit Suisse, Goldman Sachs, and Jefferies, with an option for up to 6,990,000 additional shares. The registration statement was effective as of November 19, 2020, and the offering will be governed by a prospectus.